Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

8,963 total articles

LVMH fourth-quarter revenue tops forecasts as China shows recovery

LVMH fourth-quarter revenue tops forecasts as China shows recovery

LVMH reported fourth-quarter sales of 22.7 billion euros, exceeding consensus expectations and signaling a return to growth in China. Despite the top-line beat, 2025 operating profit fell 9% and margins were pressured by currency movements, U.S. tariffs on alcohol exports and record gold prices that raised jewellery import costs.

Music Industry Shifts from Subscriber Growth to Pricing Power

Music Industry Shifts from Subscriber Growth to Pricing Power

After more than a decade of rapid adoption, streaming penetration in developed markets has largely saturated, shifting the music industry's revenue engine from subscriber expansion to pricing and monetization. Analysts at MoffettNathanson view this transition as undervalued by investors and see record labels as primary beneficiaries. The brokerage …

Gold.com Shares Jump After Analyst Raises Target as Metals Rally Strengthens

Gold.com Shares Jump After Analyst Raises Target as Metals Rally Strengthens

Gold.com (NYSE:GOLD) climbed sharply after DA Davidson analyst Michael Baker raised his price target to $53 from $45 and kept a Buy rating. Baker cites rising spot prices for gold and silver, increased market volatility linked to wider retail-to-spot spreads, and signs of strengthening unit demand supported by Google Trends data. The analyst upgrad…

Warsaw Benchmarks Reach New High as Banks, Oil and Construction Lift Market

Warsaw Benchmarks Reach New High as Banks, Oil and Construction Lift Market

Poland's equity market closed higher on Tuesday, with the WIG30 index finishing at a new all-time high. Strength in banking, oil and gas and construction names pushed the benchmark higher. Notable individual moves included strong advances for Bank Millennium and PKO Bank, while KGHM, Enea and CCC were among the heaviest decliners. Commodity and cur…

TikTok Reaches Settlement with California Plaintiff in Youth Addiction Suit

TikTok Reaches Settlement with California Plaintiff in Youth Addiction Suit

TikTok has settled a lawsuit brought by a 19-year-old California plaintiff, identified in filings as K.G.M., who alleges addiction to social media led to depression and suicidal thoughts. The settlement was disclosed by the plaintiff's lawyer, Joseph VanZandt, as jury selection opened in what had been slated as one of three bellwether trials drawn …

BofA Highlights Four Biotech Names Positioned for Potential 2026 Upside

BofA Highlights Four Biotech Names Positioned for Potential 2026 Upside

Bank of America analysts have identified four biotechnology companies they view as top investment ideas for 2026, each supported by specific commercial drivers or upcoming clinical milestones. Their selections - Argenx, KalVista Pharmaceuticals, Ocular Therapeutix and Vertex Pharmaceuticals - carry Buy ratings and price objectives that reflect proj…

Aumovio to Cut Up to 4,000 R&D Roles as It Reins in Costs

Aumovio to Cut Up to 4,000 R&D Roles as It Reins in Costs

Aumovio SE announced plans to eliminate as many as 4,000 research and development positions worldwide as part of a cost-control plan in a challenging market environment. The company said the reductions will be mostly complete by the end of 2026 and will include a voluntary redundancy program in Germany beginning in March. The move accompanies a tar…

Omeros Begins Commercial Shipments of YARTEMLEA; Shares Tick Higher

Omeros Begins Commercial Shipments of YARTEMLEA; Shares Tick Higher

Omeros Corporation's stock edged up after the company said it has completed first commercial shipments of YARTEMLEA (narsoplimab-wuug) to distributors and that transplant centers are beginning to place orders. The therapy, approved by the FDA for adults and children aged two and above, is now being administered to both adult and pediatric patients …